Based on the reported role of TFAP2D in prostate tissue and the implications of AP-2 family members in neoplasia (Cheng et al. 2002), we aimed to determine the potential role of varying TFAP2D expression levels in prostate cancer. This evidence concerns the gene TFAP2D and prostate carcinoma.